This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/515582-south-korea-astrazeneca-vaccine-over-65s/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| South Korea rules out giving AstraZeneca vaccine to over-65s | South Korea rules out giving AstraZeneca vaccine to over-65s |
| (7 months later) | |
| The Korea Disease Control and Prevention Agency (KDCA) announced on Monday that it will not give the AstraZeneca Covid-19 vaccine to individuals over the age of 65 due to a lack of data. | The Korea Disease Control and Prevention Agency (KDCA) announced on Monday that it will not give the AstraZeneca Covid-19 vaccine to individuals over the age of 65 due to a lack of data. |
| The KDCA has refused to endorse giving the AstraZeneca vaccine to elderly individuals as it awaits the company’s full clinical trial results, because officials currently fear there is not enough data about its effectiveness and impact in older recipients. | The KDCA has refused to endorse giving the AstraZeneca vaccine to elderly individuals as it awaits the company’s full clinical trial results, because officials currently fear there is not enough data about its effectiveness and impact in older recipients. |
| The decision marks a slight reversal from last week’s statement by South Korean Vice Health minister Kim Gang-lip, who said that over-65s would receive the AstraZeneca vaccine, but that a “precautionary line for cautious decision” would be added before the shots were given to elderly people. | The decision marks a slight reversal from last week’s statement by South Korean Vice Health minister Kim Gang-lip, who said that over-65s would receive the AstraZeneca vaccine, but that a “precautionary line for cautious decision” would be added before the shots were given to elderly people. |
| The AstraZeneca drug was the first Covid-19 jab to be approved in the country, so its inability to be used in over-65s throws the country’s vaccination program into chaos, as healthcare workers and elderly residents were set to be first in line to get inoculated. | The AstraZeneca drug was the first Covid-19 jab to be approved in the country, so its inability to be used in over-65s throws the country’s vaccination program into chaos, as healthcare workers and elderly residents were set to be first in line to get inoculated. |
| South Korea’s Ministry of Food and Drug Safety granted emergency use for the AstraZeneca-Oxford drug on Wednesday, over a month after the pharmaceutical company had sought approval in the country. At the time, the medical advisers who considered whether the drug is safe issued a warning against giving the jab to individuals over the age of 65. | South Korea’s Ministry of Food and Drug Safety granted emergency use for the AstraZeneca-Oxford drug on Wednesday, over a month after the pharmaceutical company had sought approval in the country. At the time, the medical advisers who considered whether the drug is safe issued a warning against giving the jab to individuals over the age of 65. |
| The two-dose vaccine will begin being rolled out to eligible citizens across the country on February 26. | The two-dose vaccine will begin being rolled out to eligible citizens across the country on February 26. |
| Around half of the countries across the EU, including France and Germany, have implemented restrictions on the use of the AstraZeneca vaccine, preventing its use in over-65s, while Belgium, Italy and Spain ruled out giving it to anyone over 55. | Around half of the countries across the EU, including France and Germany, have implemented restrictions on the use of the AstraZeneca vaccine, preventing its use in over-65s, while Belgium, Italy and Spain ruled out giving it to anyone over 55. |
| Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |